Profile and Characteristics of Analgesic Use in Myalgia Cases at Soromandi Health Center

Rahmatillah Rahmatillah

Abstract


Myalgia is a common muscle pain condition that often requires pharmacological analgesic therapy for pain management. This study aims to determine the profile and characteristics of analgesic use in myalgia patients at Puskesmas Soromandi. Data were obtained through a retrospective study of patient medical records from January to December 2023, using consecutive sampling method. The data were analyzed descriptively and presented in tables and percentages. The results show that the most common demographic groups using analgesics for myalgia were patients aged 46-65 years (46.53%), female (57.4%), and farmers (48.5%). The most frequently used analgesic was ibuprofen 400 mg (40.59%), which was more often combined with supplements rather than used as monotherapy. The most common duration for analgesic administration was 5 days (56.43%). Conclusion: Myalgia patients are generally aged 46-65 years, with a predominance of females and farmers. Ibuprofen and a 5-day duration of analgesic treatment are the most frequently applied approaches in myalgia cases at Puskesmas Soromandi.


Keywords


profile; characteristics; analgesic use; Myalga; Soromandi

Full Text:

PDF

References


Dinas Kesehatan Provinsi Nusa Tenggara Barat. (2024). Profil Kesehatan Nusa Tenggara Barat Tahun 2023. Dinas Kesehatan Provinsi Nusa Tenggara Barat. Diakses dari https://dinkes.ntbprov.go.id

Te Riele MG, Schreuder TH, van Alfen N, Bergman M, Pillen S, Smits BW, van der Wilt GJ, Groenewoud H, Voermans NC, van Engelen BG. The yield of diagnostic work-up of patients presenting with myalgia, exercise intolerance, or fatigue: A prospective observational study. Neuromuscul Disord. 2017 Mar;27(3):243-250.

Pramesi AY, Sutanto FR. Hubungan motivasi, kepercayaan dan sikap terhadap perilaku klien melakukan akupunktur pada kasus myalgia di Griya Sehat "X". Dohara Publisher Open Access Journal (DPOAJ). 2023;2(11):910-7

Sumardiyono S., Lowa NW., Azzam AM., Huda KN., Nurfauziah N. Kejadian Myalgia Pada Lansia Pasien Rawat Jalan. JRST J Ris SAINS DAN Teknol. Published Online 2017. Doi:10.30595/Jrst.V1i2.1442.

Okuyan DY, Gölen MK. Relationship between myalgia and laboratory parameters in hospitalized patients with COVID-19. J Contemp Med. 2022;12(2):306-11

Cheema, R., Chang-Miller, A., & Aslam, F. (2019). Myalgia with Elevated Inflammatory Markers in an Obese Young Female: Fibromyalgia or Polymyalgia Rheumatica?. The American journal of case reports, 20, 659–663.

Gupta, V., Ezhilarasan Santhi, S., Ravi, S., & Ramanan, E. (2022). Rheumatological and Musculoskeletal Complications in Diabetes Patients. Journal Of Endocrinology And Metabolism, 12(4-5), 117-124.

Queme, L. F., & Jankowski, M. P. (2019). Sex differences and mechanisms of muscle pain. Current opinion in physiology, 11, 1–6..

Azis, P., Juhanto, A., & Rahmawati. (2022). Hubungan postur kerja dengan kejadian myalgia pada petani di Kecamatan Bungaya Kabupaten Gowa. UNM Environmental Journals, 5(2), 1–6

Parri N, Lazzeri S. (2020). Efficacy of ibuprofen in musculoskeletal post-traumatic pain in children: A systematic review. PLoS ONE 15(12): 1-11

Isnenia, Penggunaan non-steroid antiinflamatory drug dan potensi interaksi obatnya pada pasien muskuloskeletal, Pharm J Indones, 2020;6(1):47–55

Calderon-Ospina, C. A., Nava-Mesa, M. O., & Arbeláez Ariza, C. E. (2020). Effect of Combined Diclofenac and B Vitamins (Thiamine, Pyridoxine, and Cyanocobalamin) for Low Back Pain Management: Systematic Review and Meta-analysis. Pain medicine (Malden, Mass.), 21(4), 766–781

Nava-Mesa, M. O., & Aispuru Lanche, G. R. (2021). Papel de las vitaminas B, tiamina, piridoxina y cianocobalamina en el dolor de espalda y otras condiciones musculoesqueléticas: revisión narrativa [Role of B vitamins, thiamine, pyridoxine, and cyanocobalamin in back pain and other musculoskeletal conditions: a narrative review]. Semergen, 47(8), 551–562.Monthly Index of Medical Speci

Tai, F. W. D., & McAlindon, M. E. (2021). Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Clinical medicine (London, England), 21(2), 131–134.

Schaffer, D., Florin, T., Eagle, C., Marschner, I., Singh, G., Grobler, M., Fenn, C., Schou, M., & Currow, K. M. (2006). Risk of serious NSAID-related gastrointestinal events during long-term exposure: A systematic review. The Medical Journal of Australia, 185(9), 501–506




DOI: https://doi.org/10.33394/hjkk.v12i6.13866

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.